Flammer Martina M.D.'s Form 4 filing
INSMED Inc (INSM) · filed Sep 16, 2024
- Accession no.
- 0001628280-24-040521
- Filed
- Sep 16, 2024
- Trade date
- Sep 12-16, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.07M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flammer Martina M.D.CIK 0001796960 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | MOption exerciseAcquired | +635 | $34.03 | +$21,609.05 | 106,769 | Direct | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −635 | $74.92F2 | −$47,574.2 | 106,134 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +26,969 | $34.03 | +$917,755.07 | 133,103 | Direct | |
| Sep 13, 2024 | Common Stock | SSaleDisposed | −26,969 | $74.90 | −$2,019,978.1 | 106,134 | Direct | |
| Sep 16, 2024 | Common Stock | MOption exerciseAcquired | +13,436 | $34.03 | +$457,227.08 | 119,570 | Direct | |
| Sep 16, 2024 | Common Stock | SSaleDisposed | −13,436 | $74.92F3 | −$1,006,625.12 | 106,134 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | MOption exerciseDisposed | −635 | $0.00 | $0 | 54,085 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −26,969 | $0.00 | $0 | 27,116 | Direct | |
| Sep 16, 2024 | Common Stock | MOption exerciseDisposed | −13,436 | $0.00 | $0 | 13,680 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 635 shares sold at prices ranging from $74.90 to $74.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 13,436 shares sold at prices ranging from $74.90 to $75.17 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.